WHO ICTRP trial

Effects of different doses of methylprednisolone on clinical outcomes in…

ChiCTR2100045056 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2100045056
Public title Effects of different doses of methylprednisolone on clinical outcomes in patients with severe community-acquired pneumonia
Scientific title Clinical dosage investigation of methylprednisolone sodium succinate for early adjuvant therapy in patients with severe community-acquired pneumonia
Primary sponsor Shengli Oilfield Central Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions severe community-acquired pneumonia
Interventions Control Group:Conventional treatment without glucocorticoids;Treatment group A:On the basis of the control group, methylprednisolone sodium succinate 40 mg was injected intravenously once a day for 7 days;Treatment group B:On the basis of…
Registration date Apr 4, 2021
Target size Control Group:40;Treatment group A:40;Treatment group B:40;Treatment group C:40
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations